Article info

Download PDFPDF

Original research
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up

Authors

  1. Correspondence to John B A G Haanen; j.haanen{at}nki.nl
View Full Text

Citation

van den Berg JH, Heemskerk B, van Rooij N, et al
Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up

Publication history

  • Accepted June 23, 2020
  • First published August 4, 2020.
Online issue publication 
August 04, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.